Autori: Fu Dongyue
| Naslov | Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC) (Article) |
| Autori | Syrigos Konstantinos Abert Istvan Andric Zoran G Bondarenko Igor N Dvorkin Mikhail Galic Kristina Galiulin Rinat Kuchava Vladimer Sriuranpong Virote Trukhin Dmytro Zhavrid Edvard Fu Dongyue Kassalow Laurent M Jones Stephanie Bashir Zahid |
| Info | BIODRUGS, (2021), vol. 35 br. 4, str. 417-428 |
| Projekat | Centus Biotherapeutics |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
